{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:56:46Z","timestamp":1767909406144,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.thromres.2005.06.002","type":"journal-article","created":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T18:12:55Z","timestamp":1121278375000},"page":"659-664","source":"Crossref","is-referenced-by-count":34,"title":["Early elevation of interleukin-1\u03b2 and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina"],"prefix":"10.1016","volume":"117","author":[{"given":"Gennaro","family":"Sardella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariadomenica","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Pierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Porretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Accapezzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Paroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2005.06.002_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.06.002_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9343(03)00477-7","article-title":"Coronary restenosis: a review of mechanisms and management","volume":"115","author":"Rajagopal","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2005.06.002_bib3","first-page":"S4","article-title":"Pathophysiology of coronary artery restenosis","volume":"3","author":"Schwartz","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.thromres.2005.06.002_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.CIR.0000054163.42072.D4","article-title":"Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT)","volume":"107","author":"Hong","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2005.06.002_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.06.002_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/08830189809043005","article-title":"Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist","volume":"16","author":"Dinarello","year":"1998","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.thromres.2005.06.002_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1182\/blood.V91.1.134","article-title":"Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells","volume":"91","author":"Loppnow","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.06.002_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0008-6363(99)00175-3","article-title":"Temporal and spatial distribution of interleukin-1 beta in balloon injured porcine coronary arteries","volume":"44","author":"Chamberlain","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2005.06.002_bib9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI118476","article-title":"Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor","volume":"97","author":"Shimokawa","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2005.06.002_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0008-6363(99)00215-1","article-title":"Is interleukin-1 beta a triggering factor for restenosis?","volume":"44","author":"Oemar","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2005.06.002_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.CIR.0000085567.18648.21","article-title":"Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury","volume":"108","author":"Isoda","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2005.06.002_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 in biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.thromres.2005.06.002_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1570161033386727","article-title":"Inflammation and coronary artery disease","volume":"1","author":"Ikeda","year":"2003","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.thromres.2005.06.002_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/hrt.2003.016105","article-title":"Time course of transcardiac interleukin-6 release after coronary stenting for stable angina","volume":"90","author":"Kefer","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2005.06.002_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1026188200939","article-title":"Increase in interleukin-6 in the first hour after coronary stenting: an early marker of the inflammatory response","volume":"15","author":"Aggarwal","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2005.06.002_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/039463200401700208","article-title":"Integrin beta2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia\/reperfusion in patients undergoing primary percutaneous revascularization","volume":"17","author":"Sardella","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.thromres.2005.06.002_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clim.2004.03.021","article-title":"Modulation of tachykinin and cytokine release in patients with coronary disease undergoing percutaneous revascularization","volume":"112","author":"Paroli","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.thromres.2005.06.002_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ahj.2003.12.007","article-title":"Clinical impact of stent construction and design in percutaneous coronary intervention","volume":"147","author":"Lau","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2005.06.002_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9149(99)00239-8","article-title":"Effects of an ionic and nonionic contrast agent on von Willebrand factor assessed during coronary angiography","volume":"84","author":"Dehmer","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.thromres.2005.06.002_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/pmj.2003.009431","article-title":"Drug-eluting stents: new era and new concerns","volume":"80","author":"Bhatia","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.thromres.2005.06.002_bib21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2165\/00003495-200363110-00014","article-title":"Abciximab: an updated review of its therapeutic use in patients with ischemic heart disease undergoing percutaneous coronary revascularization","volume":"63","author":"Ibbotson","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2005.06.002_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00268-004-7457-6","article-title":"Effects of preinjury administration of corticosteroids on pseudointimal hyperplasia and cytokine response in a rat model of balloon aortic injury","volume":"28","author":"Nagasaki","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.thromres.2005.06.002_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2003.12.017","article-title":"A persistent increase in C-reactive protein is a risk factor for restenosis in patients with stable angina who are not receiving statins","volume":"173","author":"Hoshida","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2005.06.002_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrd1342","article-title":"Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention","volume":"3","author":"Braddock","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.thromres.2005.06.002_bib25","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.coph.2004.03.010","article-title":"Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation","volume":"4","author":"Dinarello","year":"2004","journal-title":"Curr Opin Pharmacol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T03:07:18Z","timestamp":1586315238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384805002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0049384805002641"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2005.06.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}